• Addiss DG, Eberhard ML, Lammie PJ et al. (1993) Comparative efficacy of clearing-dose and single high-dose ivermectin and diethylcarbamazine against Wuchereria bancrofti microfilaremia. American Journal of Tropical Medicine and Hygiene 48, 178185.
  • Albiez FJ, Walter G, Kaiser A et al. (1988) Histological examination of onchocercomata after therapy with ivermectin and diethylcarbamazine in bancroftian filariasis. Tropical Medicine and Parasitology 44, 7982.
  • Moulia-Pelat J-P, Nguyen LN, Glaziou P et al. (1994) Ivermectin plus diethylcarbamazine: An additive effect on early microfilarial clearance. American Journal of Tropical Medicine and Hygiene 50, 206209.
  • Nanduri J & Kazura JW (1989) Clinical and laboratory aspects of filariasis. Clinical Microbiology Reviews 2, 3950.
  • Ottesen EA (1987) Description, mechanisms and control of reactions to treatment in the human filariasis. CIBA Foundation Symposium 127 Filariasis. John Wiley & Sons, London , pp. 265283.
  • Ottesen EA, Vijayasekaran V, Kumaraswami V et al. (1990) Controlled trial of ivermectin and diethylcarbamazine in lymphatic filariasis. New England Journal of Medicine 322, 11131117.
  • Ottesen EA (1985) Efficacy of diethylcarbamazine in eradicating infection with lymphatic dwelling filariae in humans. Reviews on Infectious Diseases 7, 341356.
  • Ottesen EA (1994) Chemotherapeutic tools for lymphatic filariasis control. Informal Consultation on New Strategies for control of lymphatic filariasis’. University Sains Malaysia, Penang 22–24 August.
  • Ottesen EA & Campbell WC (1994) Ivermectin in human medicine. Journal of Antimicrobial Chemotherapy 34, 195203.
  • Ottesen EA & Ramachandran CP (1995) Lymphatic filariasis infection and disease: Control strategies. Parasitology Today 11, 129131.
  • Peto R (1987) Why do we need systematic overviews of randomized trials Statistics in Medicine. 6, 233240.
  • Plaisier AP, Alley ES, Boatin BA et al. (1995) Irreversible effects of ivermectine on adult parasites in onchocerciasis control programme in West Africa. Journal of Infectious Diseases 172, 204210.
  • Richards FO Jr, Eberhard ML, Bryan RT et al. (1991) Comparison of high dose ivermectin and diethylcarbamazine for activity against bancroftian filariasis in Haiti. American Journal of Tropical Medicine and Hygiene 44, 310.
  • Roux PJ, Perolat Ph, Cartel J-L et al. (1989) Etude de l'ivermectine pour le traitement de la filariose lymphatique due a Wuchereria bancrofti var. Pacifica En Polynesie Francaise. Bulletin de la Société de Pathologie Exotique 82, 7281.
  • Sabry M, Gamal H, El-Masry N & Kilpatrick ME (1991) A placebo-controlled double-blind trial for the treatment of bancroftian filariasis with ivermectin or diethylcarbamazine. Transactions of the Royal Society of Tropical Medicine and Hygiene 85, 640643.
  • Taylor HR & Greene BM (1989) The status of ivermectin in the treatment of onchocerciasis. American Journal of Tropical Medicine and Hygiene 41, 460466.
  • Thacker SB (1988) Meta-analysis: A quantitative approach to research integration. Journal of the American Medical Association 259, 16851689.
  • WHO/TDR (1994) Lymphatic Filariasis Infection & Disease Control Strategies. Report of a Consultative Meeting held at the University Sains Malaysia, Penang, Malaysia, 1–30.
  • Zheng HJ, Piessen WF, Tao ZH et al. (1993) Efficacy of ivermectin for control of microfilaremia recurring after treatment with diethylcarbamazine. I. Clinical and parasitologic observations. American Journal of Tropical Medicine and Hygiene 45, 168174.